In this detailed study, Cohen and Ben-Shaul characterized Accessory Olfactory Bulb (AOB) cell responses to various conspecific urine samples in female mice across the estrous cycle. The authors found ...

NiKang Therapeutics has concluded the first cohort dosing in the open-label Phase I trial of NKT3964 as a monotherapy for ...

The University of Washington School of Medicine’s research showed that more than 70% of subjects reached undetectable MRD by ...

Zevor-cel was approved by China's National Medical Products Administration (NMPA). <li /> As of December 31, 2024, ...

In Q4 2024, the Lazard US Equity Concentrated Portfolio underperformed its benchmark. Click here to read the full commentary.

Along with TriLink's decades of chemical and biological manufacturing experience, we can now supercharge the design-build-test-learn cycle for our ... diagnostics and cell and gene therapies ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced its 2024 ...

He set the scene. The ‘top down’ approach to tackling climate change, he said, revolves around the Conference of Parties (COP) where government representatives and other stakeholders gather to ...

Travelers has launched Travelers Synergy, a new product liability coverage designed specifically for life sciences companies.

In this detailed study, Cohen and Ben-Shaul characterized the AOB cell responses to various conspecific urine samples in female mice across the estrous cycle. The authors ... However, our measure of ...

Figure 2: Schematic representation showing that ... Figure 4: Schematic diagram of the HIV infection cycle and the predicted outcome of a T-cell and B-cell vaccination as deduced from vaccination ...